Mechanisms of PDAC subtype heterogeneity and therapy response
- 15 September 2022
- journal article
- review article
- Published by Elsevier in Trends in Cancer
- Vol. 8 (12) , 1060-1071
Abstract
No abstract availableKeywords
Funding Information
- Fritz Thyssen Stiftung (1842610)
- Deutsche Krebshilfe (70112999)
- Incyte
- Deutsche Forschungsgemeinschaft (KFO 5002)
- Deutsche Forschungsgemeinschaft (P01 CA217805)
- Deutsche Forschungsgemeinschaft (RYC2020-029767)
- Boehringer Ingelheim
- National Cancer Institute
This publication has 79 references indexed in Scilit:
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced SurvivalCancer Cell, 2014
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United StatesCancer Research, 2014
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancerProceedings of the National Academy of Sciences, 2013
- Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in GlioblastomaCancer Cell, 2013
- Transforming Growth Factor-β1 (TGF-β1)-stimulated Fibroblast to Myofibroblast Differentiation Is Mediated by Hyaluronan (HA)-facilitated Epidermal Growth Factor Receptor (EGFR) and CD44 Co-localization in Lipid RaftsJournal of Biological Chemistry, 2013
- Podoplanin: emerging functions in development, the immune system, and cancerFrontiers in Immunology, 2012
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyNature Medicine, 2011
- Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent MannerCancer Cell, 2010
- Identification and characterization of a fibroblast marker: FSP1.Journal of Cell Biology, 1995